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Background. New laparoscopic devices, such as electrothermal bipolar-activated devices (LigaSure™ (LS)) or ultrasonic systems
(Harmonic® scalpel (HS)), have been applied recently to bariatric surgery allowing to reduce blood loss and surgical risks.-e aimof this study was to retrospectively compare intraoperative performance of HS and LS, postoperative results, and clinical outcomes
in a large cohort of patients undergoing LSG. Methods. Data from 422 morbidly obese patients undergoing LSG in our Bariatric
Unit at the Advanced Biomedical Sciences Department of the “Federico II” University of Naples (Italy) between January 2009 and
December 2017 were retrospectively analyzed. Subjects were divided into two groups (HS and LS), and operative time,
intraoperative complications, and postoperative (within 30 days from surgery) complications were compared. Bleeding from the
omentum or from the staple line, use of hemostatic clips, and absorbable hemostat were recorded as intraoperative complications;
hemorrhages, abscess formation, gastric leaks, fever, and mortality were considered as postoperative complications. Results.
Statistical analysis showed no diﬀerence in terms of baseline demographics between the two cohorts. Operative time (48± 9 vs
49± 6min, p � 0.646) and the rates of intraoperative and postoperative complications did not signiﬁcantly diﬀer between groups.
Conclusion. Harmonic® and LigaSure™ are both useful tools in bariatric surgery, and these two advanced power devices are user-friendly and can facilitate surgeon work; from this point of view, the choice of the energy device should be based on the preference
of the surgeon and on the hospital costs policy and availability.
1. Introduction
Laparoscopic sleeve gastrectomy (LSG) was conceived as the
ﬁrst surgical step for high-risk patients undergoing lapa-
roscopic Roux-en-Y gastric bypass (LRYGB) or bil-
iopancreatic diversion with duodenal switch (BPD-DS)
[1, 2]. -is bariatric procedure has gained popularity be-
cause of its relative simplicity and great results shown over
the years, both on weight loss- and on obesity-related
comorbidities [3–5]. Although LSG is commonly consid-
ered a safe and eﬀective procedure, some complications may
occur during and after surgery such as bleeding, staple line
leaks, and micronutrient deﬁciencies [6–11].
New laparoscopic devices, such as electrothermal
bipolar-activated devices (LigaSure™ (LS)) or ultrasonic
systems (Harmonic® scalpel (HS)), have been applied
recently to bariatric surgery allowing to reduce blood loss
and surgical risks. -ese instruments, used to achieve an
adequate hemostasis and an easier tissue dissection, have
become coresponsible of the short learning curve and of
technical simplicity of LSG.
LigaSure™ (Valleylab, Boulder, CO, USA) is an elec-
trothermal device which is used to seal vessels up to 7mm in
diameter. Its form of energy denatures collagen and elastin
of vessels and connective tissue determining vessel fusion. It
is important that a feedback-controlled response system
automatically discontinues energy delivery when the seal
cycle is complete. Harmonic Ace® (Ethicon Endo-Surgery,Inc.), instead, uses ultrasonic vibration determining eﬀects
of cutting, coaptation, coagulation, and cavitation of vessels
tissues. It is documented that it produces minimal lateral
thermal spread when dissecting near vital structures [12, 13].
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-e aim of this study was to retrospectively compare
intraoperative performance, postoperative results, and
clinical outcomes of HS and LS in a large cohort of patients
undergoing LSG.
2. Methods
Data from 422 morbidly obese patients undergoing LSG in
our Bariatric Unit at the Advanced Biomedical Sciences
Department of the “Federico II” University of Naples (Italy)
between January 2009 and December 2017 were retro-
spectively analyzed. Subjects were divided into two groups
(HS and LS); baseline demographics, such as gender, age,
height, weight, comorbidities, and previous operations were
recorded. Operative time and intraoperative and post-
operative (within 30 days from surgery) complications were
compared. Bleeding from the omentum or from the staple
line and use of hemostatic clips and absorbable hemostat
were recorded as intraoperative complications; hemor-
rhages, abscess formation, gastric leaks, fever, and mortality
were considered as postoperative complications. Patients
were men and women aged between 18 and 65 years with a
body mass index (BMI) ranging from 35 to 55 kg/m2.
Criteria of exclusion from the study were previous supra-
mesocolic surgery, ASA (American Society of Anesthesi-
ology) score 4, treated or untreated malignancies at any
stage, and conversion to open surgery.
-e study was approved by our institutional review
board, and informed consent was obtained from all subjects
before enrollment. All investigations complied with the
principles of the Declaration of Helsinki (64th WMA
General Assembly, Fortaleza, Brazil, October 2013).
2.1. Preoperative Care. All patients underwent a pre-
operative esophagogastroscopy (EGDS) to rule out gastric
lesions, and a pulmonary thromboembolism (PE) pro-
phylaxis was administered according to SICOB (Italian
Society of Bariatric Surgery) guidelines [14]. Perioperative
antiplatelet drugs administration was managed according to
validated criteria [15]. One dose of 2 g ceftriaxone was
administered intravenously 10–15min before the operation
for infection prophylaxis. In all cases, surgery started with a
laparoscopic approach. All patients had the same protocols
for anesthesia and postoperative management.
2.2. Statistical Analysis. Statistical analysis was performed
with the Statistical Package for Social Sciences (Version 20.0
for Windows; SPSS Inc, Chicago, Ill, USA). -e Mann–
Whitney U test was used for comparison between two
categories of a categorical variable, and Pearson’s chi-square
was used in order to evaluate any association between pairs
of categorical variables. A p value of <0.05 was considered
statistically signiﬁcant.
2.3. Surgical Technique. All operations were performed by
the same two experienced bariatric surgeons (Ma. Mu, Ma.
Mil).
-e choice of the device (LS or HA) used during surgery
was based on the availability of our clinic; both surgeons
used both devices from the beginning of the learning curve.
Following the preparation of the greater curvature, a
gastric sleeve was tailored using a 60mm linear stapler
(Echelon ﬂex 60®, Ethicon Endo-Surgery, Johnson &Johnson©, Somerville NJ, USA) and a 38F bougie. A total of
ﬁve to seven cartridges were used. Between the closure of the
stapler and its ﬁring, a 20 sec interval was observed in any case
[16]. A methylene blue test with 80–100mL of saline solution
was routinely performed to evaluate possible leaks. No
oversewing of the staple line was performed to prevent
bleeding or staple line leaks, but human ﬁbrin sealant
(Tisseel™, Baxter® Deerﬁeld, IL, USA) was sprayed along thesuture line [17, 18]. -e excided stomach was extracted as
previously described [19]. In all patients, a nasogastric tube
and a drainage tube were positioned at the end of the pro-
cedure. -e nasogastric tube was removed on postoperative
day (POD) 1, and a liquid diet was started on POD 3 and was
allowed for 10–15 days under strict nutritionist surveillance
[20]. An abdominal CT scan was scheduled if clinical
symptoms (fever, tachycardia, leukocytosis, and pain) were
present [21]. Patients were routinely discharged on POD 5.
3. Results
During the study period, 422 patients underwent laparo-
scopic sleeve gastrectomy for morbid obesity in our in-
stitution; 108 (25.6%) were men and 314 (74.4%) were
women; two hundred twenty-ﬁve of them were operated
using LS, and the other 197 were operated using HS.
Statistical analysis showed no diﬀerence in terms of age,
BMI, comorbidities (diabetes and hypertension), and length
of stay between the two cohorts; no diﬀerences were found in
the number of cartridges used during surgery (Table 1).
Operative time at the beginning of our learning curve
(ﬁrst 25 cases operated with LS vs ﬁrst 25 cases operated with
HA) did not signiﬁcantly diﬀer between groups (159± 7 vs
161± 9min, p � 0.384); the same results were observed
when considering operative time in last 25 cases operated
with LS vs last 25 cases operated with HA (48± 9 vs
49± 6min, p � 0.646).
Finally, the rates of intraoperative and postoperative
complications and the number of surgical revisions did not
signiﬁcantly diﬀer between groups (Table 2) (Figures 1 and
2).
4. Discussion
LSG is usually considered as a restrictive procedure, and
even though some studies have speculated about the
metabolic eﬀects on gut hormones release, this issue re-
mains controversial [22]. LSG may entail higher operative
and perioperative risks in comparison with other purely
restrictive procedures [23]; nevertheless in skilled hands, its
eﬃcacy remains undisputed, especially in the long term,
presenting a very low rate of major complications. [24].
Nowadays, diﬀerent methods are available to control
bleeding during laparoscopic procedures: energy devices,
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electrocautery, clips, vascular staplers, and intracorporeal
sutures. Electrocautery is cost-eﬀective and easy to access,
but it oﬀers less hemostatic eﬀect when compared to bipolar
or energy-based vessel-sealing devices (VSDs) and causes
more lateral thermal damage in the peripheral tissues [25].
Vessel sealing devices diﬀer in design and in the type of
energy used; the ﬁrst generation of ultrasonic VSDs was able
to seal vessels up to 3mm but currently, technological in-
novation allowed these instruments to close structures up to
7mm [26]. Okhunov et al. [27] found there are no bursting
pressure failures for the HA and LS up to 9mm vessels.
In order to choose an adequate device to minimize
intraoperative and perioperative surgical complications, we
compared two diﬀerent power devices, which were both
widely used in various kinds of surgeries.
Many studies in the literature have compared the ef-
fectiveness of these two devices in endocrine, colorectal, and
gynaecological surgery, but evidences from randomised
Table 1: Characteristics of study population.
LigaSure™ (n � 225) Harmonic Ace® (n � 197) p value
Female (n) 175 139 0.090
Age (years) 42.6± 10.73 41.2± 8.26 0.131
BMI (kg/m2) 47.2± 6.11 47.7± 5.23 0.365
Diabetes (n) 81 77 0.513
Hypertension (n) 67 75 0.072
Length of stay (days) 4.8± 1.3 5.1± 2.1 0.074
Cartridge used (n) 6.51± 0.79 6.56± 0.77 0.512
Table 2: Intraoperative and perioperative complications of the patients who underwent laparoscopic sleeve gastrectomywith LigaSure™ and
Harmonic Ace®.
LigaSure™ Harmonic Ace® p value
Intraoperative complications (n)
Omentum bleedings 25 28 0.337
Staple line bleedings 58 44 0.409
Clips 45 33 0.391
Absorbable hemostat 20 26 0.156
Postoperative complications (n)
Hemorrhage 1 1 0.924
Abscess 4 2 0.509
Leak 3 2 0.763
Fever 4 5 0.589
Mortality 0 1 0.284
Complications needing revision (n) 2 1 0.584
Mortality
Hemorrhage
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Fever
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Absorbable hemostat usage
Omentum bleedings
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Gastric pouch bleedings
Number of complications
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Figure 1: Intraoperative and postoperative complications occurred with Harmonic® and LigaSure™ in the patients’ cohort (within 30 days).
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studies, particularly in laparoscopic approach, are very
limited [28–32].
Previous studies on the topic have shown comparable
advantages of the use of LA and HA. Campagnacci et al. [33]
found no diﬀerence in the duration for colorectal surgery
between the two devices, but there was less bleeding with LS.
No statistical diﬀerence was also detected by Yavuz et al. [34]
in a randomised trial with 24 cases of laparoscopic ap-
pendicectomy. Rimonda et al. [35] analyzed results from 140
patients (31 right hemicolectomies, 69 left hemicolectomies,
and 40 anterior resections of rectum): they concluded that
LigaSure and Harmonic are both useful and safe instruments
for laparoscopic colorectal surgery with no signiﬁcant dif-
ference in terms of intraoperative/postoperative morbidity
and operative time.
About bariatric surgery, Tamis et al. [36], in an RCT on
94 patients who underwent LSG using LS or HA, found no
signiﬁcant diﬀerences in operative time and complications
and concluded that the choice between these two shears lies
with the surgeon’s preference.
To the best of our knowledge, this study involves the
largest series of patients undergoing LSG in which diﬀer-
ences between Harmonic® and LigaSure™ use is analyzed,and the results we obtained failed to show a clear advantage
in favor of one of the two devices.
-e diﬀerence in operative time observed in favor of
LigaSure™, although not signiﬁcant, seems to depend
principally on surgical dissecting diﬃculties observed in
some patients treated with HA, but these adverse events did
not lead to any clinical consequence in the postoperative
course. Moreover, the risk of intraoperative bleeding, the use
of hemostatic clips and absorbable hemostat, and the
postoperative complication rate were similar in the two
groups. By this point of view, all bleedings were managed
conservatively except for 2 cases in the LS group and 1 case
in the HA group which needed a surgical revision.
-e only case of death following surgery has been de-
termined by an acute leak on POD1 which caused a rapidly
evolving septic shock.
-e main limitation of our study is represented by its
retrospective design; furthermore, at the beginning of our
experience with LSG, operative time was not reported fol-
lowing the video recording which is currently available. -is
may have generated some inaccuracy in the evaluation of
operative time. In contrast, we included a large number of
cases, all of which underwent LSG by the same two surgeons
at a single institution, minimizing the possible bias induced
by surgeons’ expertise.
5. Conclusions
Our ﬁndings suggest that Harmonic® and LigaSure™ areboth useful in bariatric surgery, and these two advanced
power devices are user-friendly and can reduce surgeon
work load; from this point of view, the choice of the energy
device should be based on the preference of the surgeon and
on the hospital cost policy.
Data Availability
-e data used to support the ﬁndings of this study are
available from the corresponding author upon request.
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